Abstract
Interlaboratory and intermethod variation in commercial and in-house tests used for the measurement of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) limit the diagnostic value of the results from these tests. This short review summarizes published and unpublished guidelines (some developed using consensus procedures) on aCL and LA testing that are aimed at decreasing assay variation.
MeSH terms
-
Antibodies, Anticardiolipin / blood*
-
Antibodies, Anticardiolipin / genetics*
-
Antiphospholipid Syndrome / blood
-
Antiphospholipid Syndrome / diagnosis
-
Blood Coagulation Tests / methods
-
Calibration
-
Chemistry, Clinical / methods*
-
Clinical Laboratory Techniques
-
Guidelines as Topic
-
Hematology / methods*
-
Humans
-
Lupus Coagulation Inhibitor / blood*
-
Lupus Coagulation Inhibitor / genetics*
-
Lupus Erythematosus, Systemic / blood
-
Lupus Erythematosus, Systemic / diagnosis
-
Reproducibility of Results
-
Research Design
Substances
-
Antibodies, Anticardiolipin
-
Lupus Coagulation Inhibitor